Qualigen Therapeutics Stock Predictions

Healthcare > Biotechnology

Buy QLGN

*Your capital is at risk

$3.21

+0 (+0%)

At Close: Feb 17, 2026

Currently predicting for Fri, 5 Jun 2026

QLGN Prediction Chart

QLGN Predictions History

Latest community submissions for QLGN.

Predictor	Target Session	Target Price	Result	Direction	Accuracy	Score
iHustle84 Pro	Sep 23, 2020	$4.98 -99.80%	$4.93	V	98.99%	2
Judy.Gordon.112533	Sep 23, 2020	Bearish	$4.93	V	—	1
sander7100 yo bro Pro @sander7100yobro.167552	Aug 11, 2020	$6.18 -99.77%	$5.41	X	85.77%	0
JS Pro	Aug 11, 2020	$5.92 -99.78%	$5.41	X	90.57%	0
2poJeff Pro	Aug 11, 2020	$5.71 -99.79%	$5.41	X	94.45%	0

Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for QLGN with a full price path, not just a one-day call.

Price path
Approved predictor
3-month horizon

Start Forecast Request View My Forecast Requests

Featured Predictors

GPT 5.4 Reply target 48h

Select

Gemini 3.5 Reply target 48h

Select

Opus 4.7 Reply target 48h

Select

ABOUT QUALIGEN THERAPEUTICS INC.

Qualigen Therapeutics, Inc., a biotechnology company, develops novel therapeutic products for the treatment of cancer and infectious diseases. It offers FastPack, a rapid diagnostic testing system. The company is developing QN-302 for the treatment of pancreatic ductal adenocarcinoma; QN-247, a DNA coated gold nanoparticle cancer drug candidate that targets various cancers; RAS-F, a small-molecule RAS oncogene protein-protein inhibitor that block...

Read Full Profile Here

GOLDEN STAR

Ticker	Change	Signal Date
LITE $905.00	4.43%	Jun 01
N NVRI $19.53	0.87%	May 20
RUN $12.83	15.51%	May 06
GLBE $31.61	4.05%	May 05
SAP $172.39	8.56%	May 05

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by